Efficacy of Adjuvant Chemotherapy and Prognostic Factors for Patients with Extrahepatic Bile Duct Cancer

Publisher： Karger

E-ISSN： 1421-9794|61|3|152-158

ISSN： 0009-3157

Source： Chemotherapy, Vol.61, Iss.3, 2016-01, pp. : 152-158

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prognostic Factors for the Selection of Patients Eligible for Second-Line Chemotherapy in Advanced Biliary Tract Cancer

By  

Chemotherapy, Vol. 60, Iss. 2, 2015-02 ,pp. : 91-98

Karger

Access to resources Recommend Favorite

Efficacy and Safety of Platinum Combination Chemotherapy Re-Challenge for Relapsed Patients with Non-Small-Cell Lung Cancer after Postoperative Adjuvant Chemotherapy of Cisplatin plus Vinorelbine

By  

Chemotherapy, Vol. 59, Iss. 4, 2014-01 ,pp. : 307-313

Karger

Access to resources Recommend Favorite

Clinical Practice of Adjuvant Chemotherapy in Patients with Early-Stage Epithelial Ovarian Cancer

By  

Chemotherapy, Vol. 61, Iss. 6, 2016-04 ,pp. : 287-294

Karger

Access to resources Recommend Favorite

The Glasgow Prognostic Score Predicts Response to Chemotherapy in Patients with Metastatic Breast Cancer

By  

Chemotherapy, Vol. 61, Iss. 4, 2016-02 ,pp. : 217-222

Karger

Access to resources Recommend Favorite

Effect of S-1 Adjuvant Chemotherapy on Survival following Recurrence and Efficacy of First-Line Treatment in Recurrent Gastric Cancer

By  

Chemotherapy, Vol. 56, Iss. 6, 2010-11 ,pp. : 436-443

Karger

Access to resources Recommend Favorite